Cargando…
Commercial antibodies and their validation
Despite an impressive growth in the business of research antibodies a general lack of trust in commercial antibodies remains in place. A variety of issues, each one potentially causing an antibody to fail, underpin the frustrations that scientists endure. Lots of money goes to waste in buying and tr...
Autor principal: | Voskuil, JLA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197739/ https://www.ncbi.nlm.nih.gov/pubmed/25324967 http://dx.doi.org/10.12688/f1000research.4966.2 |
Ejemplares similares
-
The challenges with the validation of research antibodies
por: Voskuil, Jan L.A.
Publicado: (2017) -
How difficult is the validation of clinical biomarkers?
por: Voskuil, Jan
Publicado: (2015) -
Although it's painful: The importance of stringent antibody validation
por: Meliopoulos, Victoria A., et al.
Publicado: (2018) -
Is 'big biology' a commercial enterprise?
por: Swindells, Mark
Publicado: (2002) -
The Neglected Microbial Components of Commercial Probiotic Formulations
por: Fiore, Walter, et al.
Publicado: (2020)